Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Reuben Garner
BENC
Reuben Garner
Benchmark Co.
Wall Street Analyst
★★☆☆☆
#2310
on 13Foresight · ranked by our own returns
33%
Success Rate
-10.1%
Average Return
6 of 18 calls profitable · -25.0% vs benchmark
📈 Across the calls we could measure, roughly 33% of Reuben Garner's ratings turned a profit when each position was held for 2 year — averaging -10.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

31 Buy 7 Hold 0 Sell
Reuben's Stock Coverage 19 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return
TILE
Interface
 May 19, 2026 BUY Buy
-24.5% avg upside
8 analysts
$36.00
10.57% Upside
 +4.9%
HNI
HNI
 May 07, 2026 BUY Strong Buy
+93.6% avg upside
2 analysts
$65.00
86.40% Upside
 -12.9%
UFPI
UFP Industries
 May 01, 2026 BUY Strong Buy
+31.6% avg upside
8 analysts
$115.00
32.88% Upside
 -2.0%
BLDR
Builders Firstsource
 May 01, 2026 BUY Strong Buy
+23.3% avg upside
25 analysts
$105.00
30.19% Upside
 +6.4%
QXO
QXO Inc
 Mar 10, 2026 BUY Strong Buy
+72.5% avg upside
16 analysts
$50.00
181.50% Upside
 -17.7%
BXC
Bluelinx Holdings
 Feb 27, 2026 BUY Strong Buy
+34.6% avg upside
7 analysts
$75.00
30.22% Upside
 -23.2%
BLD
TopBuild
 Feb 27, 2026 BUY Buy
+8.2% avg upside
17 analysts
$500.00
17.22% Upside
 -8.3%
HLMN
Hillman Solutions
 Feb 20, 2026 BUY Strong Buy
+56.0% avg upside
9 analysts
$14.00
73.79% Upside
 -13.7%
TREX
Trex Company
 Feb 11, 2026 HOLD Buy
+10.0% avg upside
22 analysts
 — -15.0%
IBP
Installed Building Products
 Feb 11, 2026 HOLD Hold
+11.1% avg upside
15 analysts
 — -36.1%
NX
Quanex
 Dec 15, 2025 BUY Strong Buy
+61.7% avg upside
5 analysts
$28.00
64.65% Upside
 +13.6%
OC
Owens Corning
 Nov 06, 2025 HOLD Buy
+9.2% avg upside
22 analysts
 — +23.9%
BCC
Boise Cascade
 Nov 05, 2025 HOLD Strong Buy
+27.7% avg upside
8 analysts
 — -0.3%
MLKN
MillerKnoll
 Sep 24, 2025 HOLD Buy
+39.4% avg upside
3 analysts
 — -5.8%
FGI
FGI Industries Ltd
 Aug 13, 2025 BUY Strong Buy
-3.8% avg upside
2 analysts
$2.00
57.25% Downside
 ·
CSTE
CaesarStone Sdot-Yam
 Aug 07, 2025 BUY Buy
+1404.5% avg upside
6 analysts
$4.00
116.12% Upside
 +7.6%
JBI
Janus International Group
 May 09, 2025 BUY Buy
+86.2% avg upside
6 analysts
$10.00
86.30% Upside
 -40.5%
JELD
JELD-WEN
 Aug 07, 2024 HOLD Hold
+541.2% avg upside
16 analysts
 — -89.6%
BDC
Belden
 Feb 14, 2023 BUY Strong Buy
-4.5% avg upside
11 analysts
$108.00
12.44% Downside
 +26.6%
🔒 14 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Reuben Garner — Frequently Asked Questions
How accurate are Reuben Garner's stock ratings?
Based on the calls 13Foresight could measure, about 28% of Reuben's ratings were profitable over a one-year hold, with an average return of -10.2% per rating, or -21.9% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Reuben ranked on 13Foresight?
Reuben Garner is currently ranked #2310 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Reuben cover?
Reuben most recently has ratings on TILE, HNI, UFPI, BLDR, QXO, BXC, BLD, HLMN, TREX, IBP, NX, OC and 7 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.